產(chǎn)品詳情
簡單介紹：
Anti-CD272抗體產(chǎn)品質(zhì)量穩(wěn)定，實(shí)驗(yàn)效果明顯，貨期快，價(jià)格優(yōu)惠，歡迎垂詢訂購！我公司長期供應(yīng)**組化抗體、WB抗體、**組化試劑盒和抗體試驗(yàn)所需全部相關(guān)試劑、熒光標(biāo)記抗體、單克隆抗體、多克隆抗體、各種標(biāo)記的二抗IgG/IgM/IgD/IgA等科研實(shí)驗(yàn)抗體。Anti-CD272抗體用于**組化實(shí)驗(yàn),WB實(shí)驗(yàn),相應(yīng)的標(biāo)記抗體有HRP標(biāo)記抗體,FITC標(biāo)記,BIO等。
詳情介紹：
Rabbit Anti-CD272
Cat. Number:
Anti-CD272抗體KL-0624R
Quantity size:
0.2ml
Concentration:
1mg/ml Buffer = 0.01M TBS(pH7.4) with 1% BSA, 0.03% Proclin300 and 50% Glycerol.
Background:
B and T lymphocyte attenuator Anti-CD272抗體(BTLA), an immunoglobulin domain-containing glycoprotein with two immunoreceptor tyrosine-based inhibitory motifs. BTLA is not expressed by naive T cells, but it is induced during activation and remains expressed on T helper type 1 (T(H)1) but not T(H)2 cells. Crosslinking BTLA with antigen receptors induces its tyrosine phosphorylation and association with the Src homology domain 2 (SH2)-containing protein tyrosine phosphatases SHP-1 and SHP-2, and attenuates production of interleukin 2 (IL-2). BTLA-deficient T cells show increased proliferation, and BTLA-deficient mice have increased specific antibody responses and enhanced sensitivity to experimental autoimmune encephalomyelitis. B7x, a peripheral homolog of B7, is a ligand of BTLA. Thus, BTLA is a third inhibitory receptor on T lymphocytes with similarities to cytotoxic T lymphocyte-associated antigen 4 (CTLA-4) and programmed death 1 (PD-1).
Also known as:
B and T lymphocyte associated Anti-CD272抗體protein; B and T lymphocyte attenuator; B and T lymphocyte associated; BTLA; BTLA1; CD272 antigen; FLJ16065; MGC129743; BTLA_HUMAN; B- and T-lymphocyte attenuator; B- and T-lymphocyte-associated protein; CD272.
Specificity:
●
Rabbit Polyclonal IgG, affinity purified by Protein A.
●
Reacts with: Human, Mouse, Rat, .
●
Immunogen: KLH conjugated synthetic peptide derived from human B and T-lymphocyte attenuator.
●
Predicted Molecular Weight: 28kDa.
Storage:
Shipped at 4℃, Store at -20℃ Anti-CD272抗體(Avoid repeated freeze/thaw cycles).
Application:
WB=1:100-500 ELISA=1:500-1000 IHC-P=1:100-500 IHC-F=1:100-500 Flow-Cyt=1:20-500 ICC=1:100-500 IF=1:100-500
Not yet tested in other applications.
Optimal working dilutions Anti-CD272抗體must be determined by the end user.
Not yet tested in other applications.
Optimal working dilutions Anti-CD272抗體must be determined by the end user.
kl022Ra01 血管內(nèi)皮細(xì)胞蛋白C受體(PROCR)多克隆抗體 Polyclonal Antibody to Protein C Receptor, Endothelial (PROCR)
kl024Bo01 ***腺來源血管內(nèi)皮生長因子(EG-VEGF)多克隆抗體 Polyclonal Antibody to Endocrine Gland Derived Vascular Endothelial Growth Factor (EG-VEGF)
kl024Hu01 ***腺來源血管內(nèi)皮生長因子(EG-VEGF)多克隆抗體 Polyclonal Antibody to Endocrine Gland Derived Vascular Endothelial Growth Factor (EG-VEGF)
kl024Mu01 ***腺來源血管內(nèi)皮生長因子(EG-VEGF)多克隆抗體 Polyclonal Antibody to Endocrine Gland Derived Vascular Endothelial Growth Factor (EG-VEGF)
kl024Ra01 ***腺來源血管內(nèi)皮生長因子(EG-VEGF)多克隆抗體 Polyclonal Antibody to Endocrine Gland Derived Vascular Endothelial Growth Factor (EG-VEGF)
kl025Bo01 嗜酸粒細(xì)胞趨化因子(ECF)多克隆抗體 Polyclonal Antibody to Eosinophil Chemotactic Factor (ECF)
kl025Eq01 嗜酸粒細(xì)胞趨化因子(ECF)多克隆抗體 Polyclonal Antibody to Eosinophil Chemotactic Factor (ECF)
kl025Gu01 嗜酸粒細(xì)胞趨化因子(ECF)多克隆抗體 Polyclonal Antibody to Eosinophil Chemotactic Factor (ECF)
kl025Hu01 嗜酸粒細(xì)胞趨化因子(ECF)多克隆抗體 Polyclonal Antibody to Eosinophil Chemotactic Factor (ECF)
kl025Mu01 嗜酸粒細(xì)胞趨化因子(ECF)多克隆抗體 Polyclonal Antibody to Eosinophil Chemotactic Factor (ECF)
kl025Ra01 嗜酸粒細(xì)胞趨化因子(ECF)多克隆抗體 Polyclonal Antibody to Eosinophil Chemotactic Factor (ECF)
kl025Si01 嗜酸粒細(xì)胞趨化因子(ECF)多克隆抗體 Polyclonal Antibody to Eosinophil Chemotactic Factor (ECF)
